Elsevier

Human Immunology

Volume 73, Issue 4, April 2012, Pages 393-398
Human Immunology

The mRNA expression profile of cytokines connected to the regulation of melanocyte functioning in vitiligo skin biopsy samples and peripheral blood mononuclear cells

https://doi.org/10.1016/j.humimm.2012.01.011Get rights and content

Abstract

The expression pattern of several genes associated with different processes in melanocytes, including melanogenesis, is changed in vitiligo patients. We evaluated possible changes in the expression of interleukin (IL)–10 family cytokines (IL26, IL-28A, IL28B, IL29), their receptor subunits (IL20RB, IL22RA2, IL28RA), and genes potentially related to functioning of melanocytes (MDM1, IFNA1, IFNB1, IFNG, and ICAM1) in the case of vitiligo. We observed mRNA expression in vitiligo patients' and controls' skin and peripheral blood mononuclear cells using quantitative real-time polymerase chain reaction. The mRNA expression pattern of IL20RB, IL22RA2, IL-28A, IL28B, IL28RA, MDM1, IFNA1, IFNB1, IFNG, and ICAM1 changed in vitiligo skin and/or peripheral blood mononuclear cells (PBMC) compared with controls. All of these genes may potentially be involved in vitiligo pathogenesis through controlling or participating in different pathways that regulate survival/apoptosis, development and migration of melanocytes, and melanogenesis. This study presents additional support for our previous findings about the importance of IL-10 family cytokines in vitiligo, in particular the possible involvement of IL-22. Further studies should be considered.

Introduction

Vitiligo is an idiopathic disorder characterized by depigmented patches in skin due to loss of melanocytes. Death of the pigment cells may be caused by the factors from inside and/or outside the cell and there are many potential systems, which could be involved. However, the exact cause of destruction of epidermal melanocytes is complex and not yet fully understood. There are several theories, involving autoimmune, neural, and biochemical mechanisms [1], [2]. An autoimmune theory has a wide range of supportive evidence; abnormalities in both humoral and cell-mediated immunity have been documented in patients with vitiligo [2], [3]. In addition, vitiligo is associated with increased local and systemic cytokine production [4], [5], [6], [7], [8], [9].

In this study, we observed seven genes associated with interleukin (IL)–10 family cytokines. IL-20 receptor B (IL20RB) forms together with IL20RA or IL22RA1 receptor complexes for IL-19, IL-20 and IL-24, or IL-20 and IL-24, respectively [10], [11]. IL22RA2 (IL22BP) is a soluble monomeric protein that antagonizes IL-22 receptor complex (IL22RA1 and IL10RB) and inhibits IL-22 activity. It is produced primarily by monocytes and lymphocytes [12], [13]. IL-26 is mainly produced by T cells, monocytes, and natural killer cells [13], and it is involved in activation of STAT1 and STAT3 pathways, which are important to stimulate IL-10, IL-8, and ICAM1 production [11]. IL-28A (interferon lambda 2 (IFNL2)), IL28B (IFNL3), and IL29 (IFNL1) are recently recognized members of the IL-10 cytokine family (also categorized under the interferon [IFN] family); they form a cytokine gene cluster in region 19q13 and bind to a receptor complex combined of IL28RA and IL10RB. They are believed to have antiviral, antiproliferative, and antitumor activity [14]. Several members of interleukin-10 family cytokines (IL-10, IL-22, IL-24) and their receptors (IL10RA, IL10RB) have previously been demonstrated to be associated with vitiligo pathogenesis [15], [16].

In addition to genes associated with IL-10 family cytokines, we observed several others. Nuclear protein homolog (mouse) gene (MDM1) is located together with IL22 and IL26 in the locus 12q15; however, the biologic function of MDM1 is unknown [17], [18]. Interferon-α and -β bind to the same cell surface receptor (IFNAR). IFN-α is produced by leukocytes and keratinocytes, whereas IFN-β is synthesized by a variety of cells (fibroblasts, epithelial cells, and macrophages) [19], [20]. Both IFN-α and IFNB mRNAs have been detected in normal human melanocytes [21]. IFN-α is suggested to be important in enhancing biologic defense activities against oxidative stress [22] and may cause induction of antimelanocyte autoantibodies or activation of cytotoxic T cells [23], [24]. IFNB is thought to induce apoptosis and to have antiproliferative effects on malignant cells [25]. IFN-α, IFNB, and also IFNG enhance human B cell proliferation [26]. Both IFN-α and IFNB therapies may cause vitiligo [23], [27], [28]. IFNG is predominantly produced by natural killer cells, CD4+ and CD8+ T cells. Its mRNA expression has increased in vitiligo involved and uninvolved skin compared with control skin [15], [29]. IFNG stimulates the expression of intercellular adhesion molecule 1 (ICAM1), which is important for activating T cells and recruiting leukocytes [30], [31]. ICAM1 protein expression is upregulated in vitiligo skin and in melanocytes from perilesional vitiligo skin [32].

In the present work, we observed different cytokines, their receptors, and a few other genes potentially related to the development, proliferation, and survival of melanocytes and regulation of melanogenesis. The aim of this study was to examine the mRNA expression pattern of these genes in skin biopsy samples and peripheral blood mononuclear cells (PBMCs) derived from vitiligo patients and controls by using quantitative real-time polymerase chain reaction (QRT-PCR).

Section snippets

Subjects and methods

The protocols and informed consent forms used in this study were approved by the Ethical Review Committee on Human Research of the University of Tartu. All the participants signed a written informed consent. All patients and control subjects in the study were individuals of white ethnicity living in Estonia. Unrelated patients with vitiligo from Department of Dermatology, University of Tartu, were included in the study. The diagnosis of vitiligo was based on the following clinical signs: loss

Results

In this study, 12 genes (IL20RB, IL22RA2, IL26, IL-28A, IL28B, IL29, IL28RA, MDM1, IFNA1, IFNB1, IFNG, and ICAM1) connected to immunomodulation, melanogenesis and development and growth of melanocytes were investigated.

This study showed that the mRNA expression of IL20RB has increased in vitiligo uninvolved skin 1.4 times (p = 0.0094) when compared with controls (Fig. 1a). The expression also increased in involved vitiligo skin; however, it was statistically significant only in the case of

Discussion

Several cytokines have been suggested to participate in vitiligo pathogenesis. In the present study, we assessed the importance of cytokines and their receptors and a few other genes possibly involved in the regulation of the development and survival of melanocytes and melanogenesis [4], [5], [6], [7], [8], [9].

Our study revealed changes in the expression of cytokines and receptor genes associated to the IL-10 cytokine family. In skin the IL20RB mRNA level was higher in vitiligo patients'

Acknowledgments

This study was financially supported by the target based funding from the Estonian Ministry of Education grants SF0180043s07 and SF0180148s08, by University of Tartu research grant PARFS 07915, by the Estonian Science Foundation Grants Numbers 6576, 7549, and 7479, by the European Union through the European Regional Development Fund and by the Archimedes Foundation.

References (38)

  • X.Q. Qin et al.

    Human and mouse IFN-beta gene therapy exhibits different anti-tumor mechanisms in mouse models

    Mol Ther

    (2001)
  • D.T. Francois et al.

    Examination of the inhibitory and stimulatory effects of IFN-alpha, -beta, and -gamma on human B-cell proliferation induced by various B-cell mitogens

    Clin Immunol Immunopathol

    (1988)
  • T. Passeron et al.

    Physiopathology and genetics of vitiligo

    J Autoimmun

    (2005)
  • J.R. Schoenborn et al.

    Regulation of interferon-gamma during innate and adaptive immune responses

    Adv Immunol

    (2007)
  • L.C. Snyder et al.

    A gene amplified in a transformed mouse cell line undergoes complex transcriptional processing and encodes a nuclear protein

    J Biol Chem

    (1988)
  • E.H. Kemp et al.

    Autoimmune aspects of vitiligo

    Autoimmunity

    (2001)
  • K. Ongenae et al.

    Evidence for an autoimmune pathogenesis of vitiligo

    Pigment Cell Res

    (2003)
  • Y. Honda et al.

    Relationship between levels of soluble interleukin-2 receptors and the types and activity of vitiligo

    J Dermatol

    (1997)
  • S. Moretti et al.

    New insights into the pathogenesis of vitiligo: Imbalance of epidermal cytokines at sites of lesions

    Pigment Cell Res

    (2002)
  • Cited by (25)

    • NKG2D Defines a Subset of Skin Effector Memory CD8 T Cells with Proinflammatory Functions in Vitiligo

      2020, Journal of Investigative Dermatology
      Citation Excerpt :

      IFN-γ was found to be important for the accumulation of T cells in the skin (Harris et al., 2012). Its expression is upregulated in the skin of patients with vitiligo and is associated with increased expression of IFN-γ–related genes (Reimann et al., 2012). Lastly, IFN-γ can directly impact the function and survival of melanocytes (Yang et al., 2015).

    • Cross-talk between interferon-gamma and interleukin-18 in melanogenesis

      2016, Journal of Photochemistry and Photobiology B: Biology
    • Association analysis of class II cytokine and receptor genes in vitiligo patients

      2016, Human Immunology
      Citation Excerpt :

      IL22 was upregulated on mRNA level in PBMCs and on protein level in the sera of the patients [15]. MDM1 mRNA expression was increased in vitiligo skin and in PBMCs [12]. Together, those findings suggested an active role for IFN-γ, IL-22, and MDM1 in vitiligo pathogenesis.

    • The role of the IL-22/IL-22R1 axis in cancer

      2014, Cytokine and Growth Factor Reviews
      Citation Excerpt :

      Only recently have myeloid dendritic cells been confirmed as a specific source, from which IL-22BP is induced by retinoic acid and regulated by IL-18 through the NLRP3/NLRC4 inflammasomes [107,108]. While genetic associations between IL22RA2 and autoimmune disease or cancer have been identified [75,109–112], the role of IL-22BP in vivo remains an enigma. IL-22 and IL-22BP expression is inversely regulated in dextran sodium sulfate (DSS) colitis models [107,113].

    View all citing articles on Scopus
    View full text